L'Oreal S.A. header image

L'Oreal S.A.

OR

Equity

ISIN FR0000120321 / Valor 502805

Euronext - Euronext Paris (2026-02-27)
EUR 397.40-0.01%

L'Oreal S.A.
UMushroom community rating:

star star star star star
4.45 3 votes No rating yet
NegativeNeutralPositive

About company

L'Oréal S.A. is a French multinational cosmetics and personal-care company that develops, manufactures and markets a broad portfolio of brands across haircare, skincare, makeup, hair colour and fragrances, serving mass-market, premium and professional segments. Organized into business divisions such as Consumer Products, L'Oréal Luxe, Professional Products and Active Cosmetics, the company distributes through supermarkets and drugstores, department stores, salons, pharmacies and an expanding e-commerce channel, and maintains a global network of research and development centers to support product innovation and brand differentiation. Publicly traded on Euronext Paris and a major component of France’s benchmark indices, L'Oréal combines brand management, marketing, supply-chain scale and targeted acquisitions to compete across geographic markets and price tiers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

13.5%1Y
5.06%3Y
31.2%5Y

Performance

25.2%1Y
22.5%3Y
23.6%5Y

Volatility

Market cap

250944 M

Market cap (USD)

Daily traded volume (Shares)

441,152

Daily traded volume (Shares)

1 day high/low

343.5 / 337.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.45

3 votes
Performance:
starstarstarstarstar
4.27
Innovation:
starstarstarstarstar
4.27
Society:
starstarstarstarstar
4.73
Nature:
starstarstarstarstar
3.73
Marie-Laetitia LEYNEN
Spain, 09 Dec 2025
star star star star star
The company shows resilient performance, deep societal impact, and long-term growth potential, making it a high-quality equity for a balanced macro-focused investor.
Nargita Apte
United Kingdom, 20 Oct 2025
star star star star star
Recent Press Release - they are acquiring Kering's beauty portfolio so likely to rise
Federico Ferrari
Switzerland, 19 Oct 2025
star star star star star
L’Oréal is a strong stock to invest in. In 2023, it reported over €38 billion in revenue. The company operates in more than 150 countries. It consistently pays dividends to investors. Stable and solid, it inspires trust on the stock market.

EQUITIES OF THE SAME SECTOR

Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 0.95
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.18%USD 22.74
iRhythm Technologies Inc
iRhythm Technologies Inc iRhythm Technologies Inc Valor: 34117792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.59%USD 133.75
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.87%CHF 130.50
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.83%CAD 25.25
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.04%USD 248.43
Novo Nordisk A/S
Novo Nordisk A/S Novo Nordisk A/S Valor: 461641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%USD 37.45
Merck & Co Inc
Merck & Co Inc Merck & Co Inc Valor: 10683053
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.79%USD 123.82
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.03%USD 27.65
Abbott Laboratories
Abbott Laboratories Abbott Laboratories Valor: 903037
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 116.35